Back to search

University of British Columbia

Antibody targeted liposomal systems

Abstract

dc:description

Despite success in the development of clinically useful liposomal anticancer drugs, the advancement of targeted formulations has been limited to only a handful of successful studies in animal models of cancer. This thesis suggests that a fundamental lack of understanding of the biological fate of protein-conjugated liposomes has led to the limited success of targeted carriers. Three critical areas of fundamental importance have been identified to better understand the limited success: i) optimizing the physical and chemical attributes of protein targeted liposomal carriers for in vivo applications; ii) evaluation of the biological fate of liposomal carriers; and iii) factors influencing the association of targeting ligands with liposomes. These basic studies identify a number of parameters that will effectively facilitate the development of therapeutically useful targeted liposomes. The initial focus of this investigation was concerned with the rapid aggregation of liposomes that occurs during protein coupling on the liposome surface. By adding polyethylene glycol (PEG)-lipid anchor conjugates onto a liposome, reductions in liposome aggregation were observed. This study demonstrated that incorporation of a 2000 M.W. hydrophilic PEG polymer anchored to a phospholipid in the liposomal membrane at a final concentration of 2 mol% resulted in optimal inhibition of aggregation with no significant inhibition of target site binding and optimal circulation lifetimes. Further investigations focused on passive tumor accumulation of doxorubicin containing liposomes. These studies were completed with the objectives of assessing whether liposomes that reach extravascular spaces within tumors are available for targeting. Finally, experiments focused on the method of coupling antibody to a liposome, either through primary amines or carbohydrates. Results concluded that the conjugation of antibody via carbohydrates resulted in extended circulation lifetimes compared with antibody-conjugated through primary amines. Additional characterization raised concerns as to the stability of the antibody on the liposome in vivo and suggested that the extended plasma levels observed with the carbohydrate conjugated antibodies was a result of antibody instability on the liposome. These studies, therefore, suggest that the method of conjugation of antibody is vital to the circulation lifetimes of antibody-conjugated liposomes and will most certainly be of major importance to the accumulation of liposomes to target sites.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biochemistry and Molecular Biology
Grantor dc:publisher
University of British Columbia
Year dc:date
1997

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Harasym, Troy O.

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/6702

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Harasym, Troy O.. Antibody targeted liposomal systems. doctoral thesis, University of British Columbia, 1997. http://hdl.handle.net/2429/6702